NNK

Skip to product information
1 of 1

Selleck Chemicals

SKU:E4753-5MG

Regular price €193,00 EUR
Regular price Sale price €193,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

NNK is an activator linked to Apoptosis and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to caspase-associated cell-death signaling and survival decisions in biochemical and cell-based models.

The pathway annotation connects NNK to Apoptosis, supporting experiments that monitor caspase-associated cell-death signaling and survival decisions across biochemical, cellular, or phenotypic assay formats. This context is compatible with apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. When a fully resolved mechanism is unavailable, parallel readouts such as viability, reporter activity, morphology, localization, or biochemical conversion can still help position the compound experimentally.

Research Applications

  • Pathway perturbation studies connected to Apoptosis
  • Gain-of-function pathway-activation studies
  • Combination studies with orthogonal perturbagens
  • Mechanism-oriented follow-up using biochemical and cellular endpoints

Overall, NNK is well suited to pathway-oriented studies that need a defined compound input for Apoptosis readouts in biochemical and cell-based models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
Apoptosis
CAS No.:
64091-91-4
Molecular Weight:
207.23
Formula:
C₁₀H₁₃N₃O₂
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.